Park Ha Biological Tech Signs Underwriting Deal
Ticker: BYAH · Form: 6-K · Filed: Jan 24, 2025 · CIK: 1986247
Sentiment: neutral
Topics: underwriting-agreement, public-offering, form-6k
TL;DR
Park Ha Biological Tech inked a deal with Dawson James Securities for a public share offering.
AI Summary
On December 26, 2024, Park Ha Biological Technology Co., Ltd. entered into an underwriting agreement with Dawson James Securities, Inc. This agreement pertains to the company's proposed public offering of its ordinary shares. The filing is a Report of Foreign Private Issuer (Form 6-K) for the month of January 2025.
Why It Matters
This underwriting agreement signals the company's intention to raise capital through a public offering, which could impact its financial structure and future growth prospects.
Risk Assessment
Risk Level: medium — Underwriting agreements for public offerings carry inherent risks related to market conditions, pricing, and successful completion of the offering.
Key Players & Entities
- Park Ha Biological Technology Co., Ltd. (company) — Registrant and party to underwriting agreement
- Dawson James Securities, Inc. (company) — Representative of the underwriters
- December 26, 2024 (date) — Date of underwriting agreement
FAQ
What is the purpose of the underwriting agreement?
The underwriting agreement, entered into on December 26, 2024, is with Dawson James Securities, Inc. and pertains to the company's proposed public offering of its ordinary shares.
Who is the representative of the underwriters?
Dawson James Securities, Inc. is the representative of the underwriters in the underwriting agreement with Park Ha Biological Technology Co., Ltd.
What type of company is Park Ha Biological Technology Co., Ltd.?
Park Ha Biological Technology Co., Ltd. is a Cayman Islands exempted company.
What is the filing type and period?
The filing is a Form 6-K, Report of Foreign Private Issuer, for the month of January 2025.
Where is Park Ha Biological Technology Co., Ltd. located?
The company's principal executive offices are located at 901 & 901-2, Building C Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province, People's Republic of China.
Filing Stats: 337 words · 1 min read · ~1 pages · Grade level 13.7 · Accepted 2025-01-24 17:25:10
Key Financial Figures
- $0.00002 — of 1,200,000 ordinary shares, par value $0.00002 per share (the “Ordinary Shares&r
- $4.00 — ry Shares”), at offering price of $4.00 per share. The Company has also granted
- $697,612 — 3 Ordinary Shares. The Company received $697,612 in gross proceeds from the partial exer
Filing Documents
- ea0228704-6k_parkha.htm (6-K) — 9KB
- 0001213900-25-006610.txt ( ) — 10KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Park Ha Biological Technology Co., Ltd. Date: January 24, 2025 By: /s/ Xiaoqiu Zhang Name: Xiaoqiu Zhang Title: Chief Executive Officer, Chairperson of the Board of Directors 2